Biolase Company Profile (NASDAQ:BIOL)

About Biolase

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: BIOL
CUSIP:

Key Metrics:

Previous Close: $1.83
50 Day Moving Average: $1.65
200 Day Moving Average: $1.35
52-Week Range: $0.60 - $1.98
Trailing P/E Ratio: N/A
P/E Growth: -0.67
Market Cap: $104.86M
Outstanding Shares: 58,257,000
Beta: 1.87

Profitability:

Net Margins: -30.85%
Return on Equity: -64.30%
Return on Assets: -36.03%

Debt:

Current Ratio: 1.91%
Quick Ratio: 1.15%

Additional Links:

Companies Related to Biolase:

Consensus Ratings for Biolase (NASDAQ:BIOL) (?)

Ratings Breakdown:	No ratings tracked in the last 12 months.
Consensus Rating:	N/A (Score: NaN)
Consensus Price Target:	N/A

Analysts' Ratings History for Biolase (NASDAQ:BIOL)

Show:

No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Biolase (NASDAQ:BIOL)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/1/2016
8/1/2016	Q216	($0.03)	($0.10)	$12.90 million	$13.80 million	View	N/A
5/9/2016	Q116	($0.03)	($0.07)	$11.90 million	$11.00 million	View	N/A
3/9/2016	Q415	($0.09)	($0.02)	$13.90 million	$14.50 million	View	N/A
11/4/2015	Q315	($0.08)	($0.09)	$1.50 million	$11.20 million	View	N/A
8/5/2015	Q215	($0.06)	($0.10)	$12.30 million	$11.90 million	View	N/A
3/4/2015	Q414	($0.04)	($0.06)	$14.90 million	$13.20 million	View	N/A
11/4/2014	Q314	($0.09)	($0.08)	$11.70 million	$12.70 million	View	N/A
8/7/2014	Q214	($0.08)	($0.17)	$12.97 million	$10.20 million	View	N/A
5/12/2014	Q114	($0.05)	($0.11)	$13.29 million	$11.50 million	View	N/A
3/5/2014	Q413	($0.04)	($0.04)	$15.67 million	$15.20 million	View	N/A
11/5/2013	Q313	($0.05)	($0.10)	$16.42 million	$12.30 million	View	N/A
8/7/2013	Q2 2013	($0.04)	($0.06)	$15.69 million	$14.20 million	View	Listen
5/7/2013	Q1 2013	($0.01)	($0.06)	$14.48 million	$14.60 million	View	N/A
3/6/2013	Q4 2012		$0.05	$18.03 million	$19.10 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Biolase (NASDAQ:BIOL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Biolase (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Biolase (NASDAQ:BIOL)

Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 39.91%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/18/2016	Jack W Schuler	Major Shareholder	Buy	500	$0.80	$400.00
2/17/2016	Jack W Schuler	Major Shareholder	Buy	4,100	$0.80	$3,280.00
2/12/2016	Jack W Schuler	Major Shareholder	Buy	19,080	$0.76	$14,500.80
2/10/2016	Jack W Schuler	Major Shareholder	Buy	67,213	$0.78	$52,426.14
1/25/2016	Jack W Schuler	Major Shareholder	Buy	1,400	$0.80	$1,120.00
1/22/2016	Jack W Schuler	Major Shareholder	Buy	6,670	$0.78	$5,202.60
1/20/2016	Jack W Schuler	Major Shareholder	Buy	24,200	$0.75	$18,150.00
12/28/2015	Jack W Schuler	Major Shareholder	Buy	18,350	$0.79	$14,496.50
12/24/2015	Jack W Schuler	Major Shareholder	Buy	41,900	$0.76	$31,844.00
12/22/2015	Jack W Schuler	Major Shareholder	Buy	87,200	$0.74	$64,528.00
12/21/2015	Jack W Schuler	Major Shareholder	Buy	127,892	$0.73	$93,361.16
12/17/2015	Jack W Schuler	Major Shareholder	Buy	34,158	$0.70	$23,910.60
11/11/2015	Larry N Feinberg	Major Shareholder	Buy	54,800	$0.79	$43,292.00
11/10/2015	Paul N Clark	Director	Buy	134,579	$0.75	$100,934.25
9/24/2015	David C Dreyer	CFO	Buy	5,000	$1.20	$6,000.00
9/22/2015	David C Dreyer	CFO	Buy	5,000	$1.37	$6,850.00
9/17/2015	David C Dreyer	CFO	Buy	10,000	$1.45	$14,500.00
11/3/2014	Jeffrey M Nugent	CEO	Buy	40,465	$2.39	$96,711.35
11/3/2014	Jonathan T Md Lord	Director	Buy	101,163	$2.39	$241,779.57
11/3/2014	Larry N Feinberg	Major Shareholder	Buy	2,067,979	$2.39	$4,942,469.81
7/22/2014	Alexander K Arrow	COO	Buy	7,812	$1.92	$14,999.04
7/22/2014	Frederick D Furry	CFO	Buy	13,020	$1.92	$24,998.40
7/22/2014	Jeffrey M Nugent	CEO	Buy	52,083	$1.92	$99,999.36
7/22/2014	Paul N Clark	Director	Buy	520,833	$1.92	$999,999.36
7/18/2014	Larry N Feinberg	Major Shareholder	Buy	2,270,836	$1.92	$4,360,005.12
2/12/2014	Larry N Feinberg	Major Shareholder	Buy	2,035,033	$2.57	$5,230,034.81
1/31/2014	Larry Feinberg	major shareholder	Buy	30,798	$2.45	$75,455.10
12/19/2013	Larry Feinberg	major shareholder	Buy	340,000	$1.80	$612,000.00
12/17/2013	Larry Feinberg	major shareholder	Buy	150,400	$1.87	$281,248.00
8/23/2012	Frederick D Furry	CFO	Buy	5,075	$1.64	$8,323.00

(Data available from 1/1/2013 forward)

Latest Headlines for Biolase (NASDAQ:BIOL)

Date	Headline
	Biolase, Inc. (BIOL) Updated Broker Ratings - NewsDen (NASDAQ:BIOL) newsden.net - September 28 at 3:38 PM
	Interested Penny Stock Investors Keen on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 28 at 3:38 PM
	Arens Appointed Biolase EMEA VP - Photonics.com (NASDAQ:BIOL) www.photonics.com - September 28 at 3:38 PM
	Global Dental Surgical Equipment Market 2016: Biolase Inc, Danaher Corp, Midmark Corp, PLANMECA Oy, Sirona ... - Digital Journal (NASDAQ:BIOL) www.digitaljournal.com - September 27 at 3:51 PM
	Penny Stock Investors are Growing Curious About BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 27 at 3:51 PM
	Under the Microscope: Zeroing in on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 27 at 8:26 AM
	Global Dental Diagnostic Equipment Market 2016: Biolase Inc, Danaher Corp, Midmark Corp, PLANMECA Oy, Sirona ... - NewsMaker (press release) (NASDAQ:BIOL) www.newsmaker.com.au - September 26 at 3:58 PM
	ETF’s with exposure to BIOLASE, Inc. : September 26, 2016 (NASDAQ:BIOL) www.capitalcube.com - September 26 at 3:58 PM
	Keen Investors Find News on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 24 at 8:05 AM
	BIOLASE Names Holger Arens Vice President, Managing Director EMEA - Yahoo Finance (NASDAQ:BIOL) finance.yahoo.com - September 23 at 3:18 PM
	Under the Microscope, Zeroing in at BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 22 at 4:00 PM
	Penny Stock Investors Keen on Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 22 at 8:04 AM
	BIOLASE Names Holger Arens Vice President, Managing Director EMEA - Business Wire (press release) (NASDAQ:BIOL) www.businesswire.com - September 22 at 8:04 AM
	BIOLASE Names Holger Arens Vice President, Managing Director EMEA (NASDAQ:BIOL) www.publicnow.com - September 22 at 8:04 AM
	Penny Stock Investors Take an Interest in BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 21 at 8:23 AM
	Under the Microscope: Getting a Closer Look at Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 20 at 9:07 AM
	prateek cv (NASDAQ:BIOL) www.slideshare.net - September 17 at 8:38 AM
	Biolase Technology Incorporated (NASDAQ:BIOL) Shorted Shares Increased 1.16% After Market Selling - Post News (NASDAQ:BIOL) www.kentuckypostnews.com - September 16 at 3:47 PM
	Keen Investors Seek Information on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 16 at 3:47 PM
	Top Wall Street Stories: BIOLASE, Inc. (NASDAQ:BIOL), Verizon Communications Inc. (NYSE:VZ), Elmira Savings Bank ... - KC Register (NASDAQ:BIOL) www.kcregister.com - September 15 at 12:47 PM
	Stock Update, a Closer Look at BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 15 at 12:47 PM
	Penny Stock Investors Highly Curious in Shares of BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 14 at 3:52 PM
	Keen Investors Narrowing Their Focus on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - September 14 at 3:52 PM
	BIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project - Business Wire (press release) (NASDAQ:BIOL) www.businesswire.com - September 14 at 3:52 PM
	Biolase (BIOL), The McGuire Institute Enter Agreement for Landmark Laser Perio Research Project (NASDAQ:BIOL) www.streetinsider.com - September 13 at 8:43 AM
	5:16 pm Biolase enters into clinical research agreement with McGuire Institute for laser perio research project (NASDAQ:BIOL) finance.yahoo.com - September 13 at 8:43 AM
	BIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project (NASDAQ:BIOL) www.publicnow.com - September 13 at 8:43 AM
	Learn details of the world dental equipment market - opportunities and forecasts, 2014 - 2022 (NASDAQ:BIOL) www.whatech.com - September 7 at 8:57 PM
	ETF’s with exposure to BIOLASE, Inc. : August 29, 2016 (NASDAQ:BIOL) www.capitalcube.com - August 29 at 4:27 PM
	Now Available – Worldwide Directed Energy-Based Surgical Systems Market Report 2015-2025 (NASDAQ:BIOL) www.medgadget.com - August 26 at 11:55 AM
	Directed Energy-Based Surgical Systems Market Segments and Key Trends 2015-2025 (NASDAQ:BIOL) reports.pr-inside.com - August 17 at 9:18 PM
	Dental Equipment Market Sale Value US$5.5 Bn at 2011,Estimated to Reach US$7.6 Bn by 2018 - Research Proved (NASDAQ:BIOL) www.sbwire.com - August 16 at 3:57 PM
	Dental Equipment Market by Product & End User - Global Forecast to 2021 (NASDAQ:BIOL) www.prnewswire.com - August 16 at 3:57 PM
	Stock Update on BIOLASE, Inc. (NASDAQ:BIOL) - Duncan Research (NASDAQ:BIOL) www.duncanindependent.com - August 11 at 3:53 PM
	Palamina Announces Closing of Oversubscribed $1.2M Private Placement (NASDAQ:BIOL) www.4-traders.com - August 8 at 9:16 PM
	BIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights of Security (NASDAQ:BIOL) biz.yahoo.com - August 8 at 9:16 PM
	BIOLASE, INC Financials (NASDAQ:BIOL) finance.yahoo.com - August 6 at 4:16 PM
	Form 4 BIOLASE, INC For: Aug 01 Filed by: CLARK PAUL N - StreetInsider.com (NASDAQ:BIOL) www.streetinsider.com - August 4 at 9:36 PM
	BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat (NASDAQ:BIOL) biz.yahoo.com - August 2 at 3:53 PM
	Dental Surgical Instrument Research Industry Trends, Growth – Forecast to 2027 (NASDAQ:BIOL) www.einnews.com - August 2 at 8:38 AM
	BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BIOL) biz.yahoo.com - August 1 at 3:49 PM
	Q2 2016 BIOLASE Inc Earnings Release - After Market Close (NASDAQ:BIOL) biz.yahoo.com - August 1 at 7:07 AM
	BIOLASE Reports 2016 Second Quarter and Six-Month Results (NASDAQ:BIOL) www.publicnow.com - August 1 at 6:41 AM
	BIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement (NASDAQ:BIOL) www.publicnow.com - August 1 at 6:21 AM
	Biolase reports 2Q loss (NASDAQ:BIOL) sg.finance.yahoo.com - August 1 at 6:20 AM
	New report: Dental equipment market is projected to reach 7.52 billion USD by 2021 (NASDAQ:BIOL) www.whatech.com - July 25 at 4:21 PM
	BIOLASE : reg; to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL) www.4-traders.com - July 25 at 8:38 AM
	BIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 (NASDAQ:BIOL) www.publicnow.com - July 25 at 6:28 AM
	Glaukos CFO to Retire in 2017 (NASDAQ:BIOL) www.ocbj.com - July 24 at 8:33 AM
	Stock Up Nicely This Week: BIOLASE, Inc. (NASDAQ:BIOL) - TGP (NASDAQ:BIOL) telanaganapress.com - July 23 at 3:47 PM